Non Clear Cell Renal Carcinoma
2 clinical trials · Condition
◉ Watch Non Clear Cell Renal Carcinoma
| Record | Firm | Date |
|---|---|---|
| Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma (NCT05220267) | Sun Yat-sen University | 2022-02-28 |
| RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe (NCT00688753) | Novartis Pharmaceuticals | 2009-07-01 |
Track Non Clear Cell Renal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.